NCT05492123 2024-01-05
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer
Hospital Israelita Albert Einstein
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05173272 2023-12-27
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Sichuan Cancer Hospital and Research Institute
Phase 3 Recruiting
NCT05511623 2023-09-11
Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Recruiting
NCT05872724 2023-05-24
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Suzhou Municipal Hospital
Phase 2 Recruiting